Literature DB >> 15032582

Autoimmune and inflammatory mechanisms in atherosclerosis.

Georg Wick1, Michael Knoflach, Qingbo Xu.   

Abstract

The present review focuses on the concept that cellular and humoral immunity to the phylogenetically highly conserved antigen heat shock protein 60 (HSP60) is the initiating mechanism in the earliest stages of atherosclerosis. Subjecting arterial endothelial cells to classical atherosclerosis risk factors leads to the expression of HSP60 that then may serve as a target for pre-existent cross-reactive antimicrobial HSP60 immunity or bona fide autoimmune reactions induced by biochemically altered autologous HSP60. Endothelial cells can also bind microbial or autologous HSP60 via Toll-like receptors, providing another possibility for targetting adaptive or innate immunological effector mechanisms.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15032582     DOI: 10.1146/annurev.immunol.22.012703.104644

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  113 in total

1.  Immune dysregulation accelerates atherosclerosis and modulates plaque composition in systemic lupus erythematosus.

Authors:  Aleksandar K Stanic; Charles M Stein; Adam C Morgan; Sergio Fazio; MacRae F Linton; Edward K Wakeland; Nancy J Olsen; Amy S Major
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-24       Impact factor: 11.205

Review 2.  Hold me tight: Role of the heat shock protein family of chaperones in cardiac disease.

Authors:  Monte S Willis; Cam Patterson
Journal:  Circulation       Date:  2010-10-26       Impact factor: 29.690

Review 3.  Molecular chaperones and heat shock proteins in atherosclerosis.

Authors:  Qingbo Xu; Bernhard Metzler; Marjan Jahangiri; Kaushik Mandal
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-11-04       Impact factor: 4.733

4.  Atypical mycobacteria in a superficial femoral artery occlusion.

Authors:  C Determann; A T Hill; H Monaghan; S C A Fraser
Journal:  BMJ Case Rep       Date:  2011-03-10

5.  Marked acceleration of atherosclerosis after Lactobacillus casei-induced coronary arteritis in a mouse model of Kawasaki disease.

Authors:  Shuang Chen; Youngho Lee; Timothy R Crother; Michael Fishbein; Wenxuan Zhang; Atilla Yilmaz; Kenichi Shimada; Danica J Schulte; Thomas J A Lehman; Prediman K Shah; Moshe Arditi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-05-24       Impact factor: 8.311

6.  Alpha-lipoic acid attenuates atherosclerotic lesions and inhibits proliferation of vascular smooth muscle cells through targeting of the Ras/MEK/ERK signaling pathway.

Authors:  Woo-Ram Lee; Aekyong Kim; Kee-Sik Kim; Yoon-Yub Park; Ji-Hyun Park; Kyung-Hyun Kim; Soo-Jung Kim; Kwan-Kyu Park
Journal:  Mol Biol Rep       Date:  2012-06       Impact factor: 2.316

Review 7.  Dysregulation of T-cell function in the elderly : scientific basis and clinical implications.

Authors:  Tamas Fulop; Anis Larbi; Anders Wikby; Eugenio Mocchegiani; Katsuiku Hirokawa; Graham Pawelec
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

8.  Association of serum soluble heat shock protein 60 with toll-like receptor 4 polymorphism and severity of coronary artery disease.

Authors:  K Mandal; A R Afzal; S J D Brecker; J Poloniecki; Q Xu; M Jahangiri
Journal:  Heart       Date:  2006-05       Impact factor: 5.994

9.  Autoimmunity and atherosclerosis: functional polymorphism of PTPN22 is associated with phenotypes related to the risk of atherosclerosis. The Cardiovascular Risk in Young Finns Study.

Authors:  M Pertovaara; A Raitala; M Juonala; M Kähönen; T Lehtimäki; J S A Viikari; O T Raitakari; M Hurme
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

10.  Protective effect of human heat shock protein 60 suggested by its association with decreased seropositivity to pathogens.

Authors:  A Steptoe; A Shamaei-Tousi; A Gylfe; L Bailey; S Bergström; A R Coates; B Henderson
Journal:  Clin Vaccine Immunol       Date:  2007-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.